Global Rheumatoid Arthritis Devices Market Growth 2021-2026

Global Rheumatoid Arthritis Devices Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rheumatoid Arthritis Devices Consumption 2016-2026
2.1.2 Rheumatoid Arthritis Devices Consumption CAGR by Region
2.2 Rheumatoid Arthritis Devices Segment by Type
2.2.1 Implantable Joint Prostheses
2.2.2 Spinal Devices
2.2.3 Other
2.3 Rheumatoid Arthritis Devices Sales by Type
2.3.1 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Rheumatoid Arthritis Devices Sale Price by Type (2016-2021)
2.4 Rheumatoid Arthritis Devices Segment by Application
2.4.1 Elderly
2.4.2 Young adults
2.5 Rheumatoid Arthritis Devices Sales by Application
2.5.1 Global Rheumatoid Arthritis Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Rheumatoid Arthritis Devices Sale Price by Application (2016-2021)

3 Global Rheumatoid Arthritis Devices by Company
3.1 Global Rheumatoid Arthritis Devices Sales Market Share by Company
3.1.1 Global Rheumatoid Arthritis Devices Sales by Company (2019-2021)
3.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2021)
3.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Company
3.2.1 Global Rheumatoid Arthritis Devices Revenue by Company (2019-2021)
3.2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2021)
3.3 Global Rheumatoid Arthritis Devices Sale Price by Company
3.4 Global Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rheumatoid Arthritis Devices Product Location Distribution
3.4.2 Players Rheumatoid Arthritis Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Rheumatoid Arthritis Devices by Region
4.1 Global Rheumatoid Arthritis Devices by Region
4.1.1 Global Rheumatoid Arthritis Devices Sales by Region
4.1.2 Global Rheumatoid Arthritis Devices Revenue by Region
4.2 Americas Rheumatoid Arthritis Devices Sales Growth
4.3 APAC Rheumatoid Arthritis Devices Sales Growth
4.4 Europe Rheumatoid Arthritis Devices Sales Growth
4.5 Middle East & Africa Rheumatoid Arthritis Devices Sales Growth

5 Americas
5.1 Americas Rheumatoid Arthritis Devices Sales by Country
5.1.1 Americas Rheumatoid Arthritis Devices Sales by Country (2016-2021)
5.1.2 Americas Rheumatoid Arthritis Devices Revenue by Country (2016-2021)
5.2 Americas Rheumatoid Arthritis Devices Sales by Type
5.3 Americas Rheumatoid Arthritis Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Rheumatoid Arthritis Devices Sales by Region
6.1.1 APAC Rheumatoid Arthritis Devices Sales by Region (2016-2021)
6.1.2 APAC Rheumatoid Arthritis Devices Revenue by Region (2016-2021)
6.2 APAC Rheumatoid Arthritis Devices Sales by Type
6.3 APAC Rheumatoid Arthritis Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Rheumatoid Arthritis Devices by Country
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Country (2016-2021)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Country (2016-2021)
7.2 Europe Rheumatoid Arthritis Devices Sales by Type
7.3 Europe Rheumatoid Arthritis Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Rheumatoid Arthritis Devices by Country
8.1.1 Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Rheumatoid Arthritis Devices Sales by Type
8.3 Middle East & Africa Rheumatoid Arthritis Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rheumatoid Arthritis Devices Distributors
10.3 Rheumatoid Arthritis Devices Customer

11 Global Rheumatoid Arthritis Devices Market Forecast
11.1 Global Rheumatoid Arthritis Devices Forecast by Region
11.1.1 Global Rheumatoid Arthritis Devices Forecast by Regions (2021-2026)
11.2.2 Global Rheumatoid Arthritis Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Rheumatoid Arthritis Devices Forecast by Type
11.7 Global Rheumatoid Arthritis Devices Forecast by Application

12 Key Players Analysis
12.1 Active Implants LLC
12.1.1 Active Implants LLC Company Information
12.1.2 Active Implants LLC Rheumatoid Arthritis Devices Product Offered
12.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Active Implants LLC Main Business Overview
12.1.5 Active Implants LLC Latest Developments
12.2 Anika Therapeutics, Inc.
12.2.1 Anika Therapeutics, Inc. Company Information
12.2.2 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Offered
12.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Anika Therapeutics, Inc. Main Business Overview
12.2.5 Anika Therapeutics, Inc. Latest Developments
12.3 Arthrex, Inc.
12.3.1 Arthrex, Inc. Company Information
12.3.2 Arthrex, Inc. Rheumatoid Arthritis Devices Product Offered
12.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Arthrex, Inc. Main Business Overview
12.3.5 Arthrex, Inc. Latest Developments
12.4 Asahi Kasei Pharma Corporation
12.4.1 Asahi Kasei Pharma Corporation Company Information
12.4.2 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Offered
12.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Asahi Kasei Pharma Corporation Main Business Overview
12.4.5 Asahi Kasei Pharma Corporation Latest Developments
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Company Information
12.5.2 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Offered
12.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 B. Braun Melsungen AG Main Business Overview
12.5.5 B. Braun Melsungen AG Latest Developments
12.6 CONMED Corporation
12.6.1 CONMED Corporation Company Information
12.6.2 CONMED Corporation Rheumatoid Arthritis Devices Product Offered
12.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 CONMED Corporation Main Business Overview
12.6.5 CONMED Corporation Latest Developments
12.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
12.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Company Information
12.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Offered
12.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business Overview
12.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
12.8 Integra Lifesciences Corporation
12.8.1 Integra Lifesciences Corporation Company Information
12.8.2 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Offered
12.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Integra Lifesciences Corporation Main Business Overview
12.8.5 Integra Lifesciences Corporation Latest Developments
12.9 Johnson & Johnson (DePuy Synthes Inc.)
12.9.1 Johnson & Johnson (DePuy Synthes Inc.) Company Information
12.9.2 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Offered
12.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Johnson & Johnson (DePuy Synthes Inc.) Main Business Overview
12.9.5 Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
12.10 Novartis AG
12.10.1 Novartis AG Company Information
12.10.2 Novartis AG Rheumatoid Arthritis Devices Product Offered
12.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis AG Main Business Overview
12.10.5 Novartis AG Latest Developments
12.11 RTI Surgical, Inc.
12.11.1 RTI Surgical, Inc. Company Information
12.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Offered
12.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 RTI Surgical, Inc. Main Business Overview
12.11.5 RTI Surgical, Inc. Latest Developments
12.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
12.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Company Information
12.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Offered
12.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business Overview
12.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
12.13 Setpoint Medical Corporation
12.13.1 Setpoint Medical Corporation Company Information
12.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Offered
12.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Setpoint Medical Corporation Main Business Overview
12.13.5 Setpoint Medical Corporation Latest Developments
12.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
12.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Company Information
12.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Offered
12.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business Overview
12.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
12.15 Stryker Corporation (OrthoSpace Ltd.)
12.15.1 Stryker Corporation (OrthoSpace Ltd.) Company Information
12.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Offered
12.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Stryker Corporation (OrthoSpace Ltd.) Main Business Overview
12.15.5 Stryker Corporation (OrthoSpace Ltd.) Latest Developments
12.16 UCB Pharma S.A.
12.16.1 UCB Pharma S.A. Company Information
12.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Offered
12.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 UCB Pharma S.A. Main Business Overview
12.16.5 UCB Pharma S.A. Latest Developments
12.17 Zimmer Biomet
12.17.1 Zimmer Biomet Company Information
12.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Product Offered
12.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Zimmer Biomet Main Business Overview
12.17.5 Zimmer Biomet Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Rheumatoid Arthritis Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Implantable Joint Prostheses
Table 3. Major Players of Spinal Devices
Table 4. Major Players of Other
Table 5. Global Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 6. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
Table 7. Global Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & ($ million)
Table 8. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2021)
Table 9. Global Rheumatoid Arthritis Devices Sale Price by Type (2016-2021)
Table 10. Global Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 11. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Table 12. Global Rheumatoid Arthritis Devices Value by Application (2016-2021)
Table 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2021)
Table 14. Global Rheumatoid Arthritis Devices Sale Price by Application (2016-2021)
Table 15. Global Rheumatoid Arthritis Devices Sales by Company (2019-2021) & (K Units)
Table 16. Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2021)
Table 17. Global Rheumatoid Arthritis Devices Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2021)
Table 19. Global Rheumatoid Arthritis Devices Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution and Sales Area
Table 21. Players Rheumatoid Arthritis Devices Products Offered
Table 22. Rheumatoid Arthritis Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rheumatoid Arthritis Devices Sales by Region (2016-2021) (K Units)
Table 26. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021)
Table 27. Global Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2016-2021)
Table 29. Americas Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 30. Americas Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021)
Table 31. Americas Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021)
Table 33. Americas Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 34. Americas Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
Table 35. Americas Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 36. Americas Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Table 37. APAC Rheumatoid Arthritis Devices Sales by Region (2016-2021) & (K Units)
Table 38. APAC Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021)
Table 39. APAC Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Rheumatoid Arthritis Devices Revenue Market Share by Region (2016-2021)
Table 41. APAC Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 42. APAC Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
Table 43. APAC Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 44. APAC Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Table 45. Europe Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 46. Europe Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021)
Table 47. Europe Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021)
Table 49. Europe Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 50. Europe Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
Table 51. Europe Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 52. Europe Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Rheumatoid Arthritis Devices
Table 62. Key Application and Potential Industries of Rheumatoid Arthritis Devices
Table 63. Key Challenges of Rheumatoid Arthritis Devices
Table 64. Key Trends of Rheumatoid Arthritis Devices
Table 65. Rheumatoid Arthritis Devices Distributors List
Table 66. Rheumatoid Arthritis Devices Customer List
Table 67. Global Rheumatoid Arthritis Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Rheumatoid Arthritis Devices Consumption Market Forecast by Region
Table 69. Global Rheumatoid Arthritis Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Rheumatoid Arthritis Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Rheumatoid Arthritis Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Rheumatoid Arthritis Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Rheumatoid Arthritis Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Rheumatoid Arthritis Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Rheumatoid Arthritis Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Rheumatoid Arthritis Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Rheumatoid Arthritis Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Rheumatoid Arthritis Devices Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Rheumatoid Arthritis Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Rheumatoid Arthritis Devices Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Rheumatoid Arthritis Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Application (2021-2026)
Table 87. Active Implants LLC Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Active Implants LLC Rheumatoid Arthritis Devices Product Offered
Table 89. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Active Implants LLC Main Business
Table 91. Active Implants LLC Latest Developments
Table 92. Anika Therapeutics, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Offered
Table 94. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Anika Therapeutics, Inc. Main Business
Table 96. Anika Therapeutics, Inc. Latest Developments
Table 97. Arthrex, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Arthrex, Inc. Rheumatoid Arthritis Devices Product Offered
Table 99. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Arthrex, Inc. Main Business
Table 101. Arthrex, Inc. Latest Developments
Table 102. Asahi Kasei Pharma Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Offered
Table 104. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Asahi Kasei Pharma Corporation Main Business
Table 106. Asahi Kasei Pharma Corporation Latest Developments
Table 107. B. Braun Melsungen AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Offered
Table 109. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. B. Braun Melsungen AG Main Business
Table 111. B. Braun Melsungen AG Latest Developments
Table 112. CONMED Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. CONMED Corporation Rheumatoid Arthritis Devices Product Offered
Table 114. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. CONMED Corporation Main Business
Table 116. CONMED Corporation Latest Developments
Table 117. EMulate Therapeutics, Inc. (Nativis, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Offered
Table 119. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business
Table 121. EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
Table 122. Integra Lifesciences Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Offered
Table 124. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Integra Lifesciences Corporation Main Business
Table 126. Integra Lifesciences Corporation Latest Developments
Table 127. Johnson & Johnson (DePuy Synthes Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Offered
Table 129. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Johnson & Johnson (DePuy Synthes Inc.) Main Business
Table 131. Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
Table 132. Novartis AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 133. Novartis AG Rheumatoid Arthritis Devices Product Offered
Table 134. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Novartis AG Main Business
Table 136. Novartis AG Latest Developments
Table 137. RTI Surgical, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 138. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Offered
Table 139. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. RTI Surgical, Inc. Main Business
Table 141. RTI Surgical, Inc. Latest Developments
Table 142. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 143. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Offered
Table 144. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business
Table 146. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
Table 147. Setpoint Medical Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 148. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Offered
Table 149. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. Setpoint Medical Corporation Main Business
Table 151. Setpoint Medical Corporation Latest Developments
Table 152. Smith & Nephew plc (Osiris Therapeutics, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 153. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Offered
Table 154. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business
Table 156. Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
Table 157. Stryker Corporation (OrthoSpace Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 158. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Offered
Table 159. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Stryker Corporation (OrthoSpace Ltd.) Main Business
Table 161. Stryker Corporation (OrthoSpace Ltd.) Latest Developments
Table 162. UCB Pharma S.A. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 163. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Offered
Table 164. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. UCB Pharma S.A. Main Business
Table 166. UCB Pharma S.A. Latest Developments
Table 167. Zimmer Biomet Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 168. Zimmer Biomet Rheumatoid Arthritis Devices Product Offered
Table 169. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 170. Zimmer Biomet Main Business
Table 171. Zimmer Biomet Latest Developments
List of Figures
Figure 1. Picture of Rheumatoid Arthritis Devices
Figure 2. Rheumatoid Arthritis Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rheumatoid Arthritis Devices Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Rheumatoid Arthritis Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Rheumatoid Arthritis Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Implantable Joint Prostheses
Figure 10. Product Picture of Spinal Devices
Figure 11. Product Picture of Other
Figure 12. Global Rheumatoid Arthritis Devices Sales Market Share by Type in 2020
Figure 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2021)
Figure 14. Rheumatoid Arthritis Devices Consumed in Elderly
Figure 15. Global Rheumatoid Arthritis Devices Market: Elderly (2016-2021) & (K Units)
Figure 16. Rheumatoid Arthritis Devices Consumed in Young adults
Figure 17. Global Rheumatoid Arthritis Devices Market: Young adults (2016-2021) & (K Units)
Figure 18. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021)
Figure 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Application in 2020
Figure 20. Rheumatoid Arthritis Devices Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Rheumatoid Arthritis Devices Revenue Market Share by Company in 2020
Figure 22. Global Rheumatoid Arthritis Devices Sales Market Share by Regions (2016-2021)
Figure 23. Global Rheumatoid Arthritis Devices Revenue Market Share by Region in 2020
Figure 24. Americas Rheumatoid Arthritis Devices Sales 2016-2021 (K Units)
Figure 25. Americas Rheumatoid Arthritis Devices Revenue 2016-2021 ($ Millions)
Figure 26. APAC Rheumatoid Arthritis Devices Sales 2016-2021 (K Units)
Figure 27. APAC Rheumatoid Arthritis Devices Revenue 2016-2021 ($ Millions)
Figure 28. Europe Rheumatoid Arthritis Devices Sales 2016-2021 (K Units)
Figure 29. Europe Rheumatoid Arthritis Devices Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Rheumatoid Arthritis Devices Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Rheumatoid Arthritis Devices Revenu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs